Humacyte

Business

TD Cowen maintains Buy rating on Humacyte with $10 target By Investing.com

On Monday, TD Cowen reaffirmed its Buy rating on shares of Humacyte (NASDAQ:HUMA) with a consistent price target of $10.00.…

Read More »
Back to top button